January Social Media Round-Up—Celebrating 175, Discussing AI, and Attending CES 2024
One month into the new year and Pfizer is already got plenty to show for it.
January’s social media round-up features a dispatch from Las Vegas’s CES conference, our CTO’s insight into artificial intelligence’s impact on cancer, and an impassioned pleas from our CEO.
Catch up below:
CEO Albert Bourla kicks off Pfizer’s 175th anniversary celebration:
Chief People Experience Office Payal Sahni Becker celebrates Pfizer’s inclusion on Fortune’s Most Admired Companies list:
CEO Albert Bourla TIME Op-Ed urging action for Israeli hostages in Gaza:
Chief Marketing Officer Drew Panayiotou reports back on his experience at CES 2024:
CEO Albert Bourla lists some of the company’s 2023 highlights:
Chief Digital and Technology Officer Lidia Fonseca shares her discussion with Forbes about AI’s impact on healthcare and the future of cancer treatment:
02.23.2024 Diversity & Inclusion Employees Responsibility Pfizer’s Statement on Results of Fifth Annual Pay Equity Study Among Colleagues Worldwide 02.12.2024 Cancer Employees History Patient Centricity Pfizer Kicks Off 175th Anniversary by Looking Back at Legacy and Ahead to the Future 02.06.2024 Medicines Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer 02.05.2024 Cancer Health Equity Oncology Partnerships “Change the Odds” Brings Pfizer Together with the American Cancer Society to Bridge the Gap in Cancer Care Disparities